Goldman Sachs’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-20,900
| Closed | -$6.82M | – | 6312 |
|
|
2025
Q2 | $6.82M | Buy |
20,900
+4,900
| +31% | +$1.36M | ﹤0.01% | 3121 |
|
|
2025
Q1 | $4.32M | Buy |
+16,000
| New | +$4.11M | ﹤0.01% | 3502 |
|
|
2021
Q3 | – | Sell |
-25,000
| Closed | -$4.24M | – | 6199 |
|
|
2021
Q2 | $4.24M | Sell |
25,000
-5,000
| -17% | -$732K | ﹤0.01% | 3483 |
|
|
2021
Q1 | $4.24M | Sell |
30,000
-35,000
| -54% | -$5.27M | ﹤0.01% | 3288 |
|
|
2020
Q4 | $8.45M | Buy |
65,000
+20,000
| +44% | +$2.67M | ﹤0.01% | 2597 |
|
|
2020
Q3 | $6.55M | Buy |
45,000
+37,700
| +516% | +$5.36M | ﹤0.01% | 2694 |
|
|
2020
Q2 | $1.08M | Sell |
7,300
-3,100
| -30% | -$418K | ﹤0.01% | 3894 |
|
|
2020
Q1 | $1.13M | Sell |
10,400
-123,600
| -92% | -$14.3M | ﹤0.01% | 3667 |
|
|
2019
Q4 | $15.4M | Sell |
134,000
-279,700
| -68% | -$27.9M | ﹤0.01% | 2077 |
|
|
2019
Q3 | $33.3M | Buy |
413,700
+330,600
| +398% | +$26.2M | 0.01% | 1401 |
|
|
2019
Q2 | $6.03M | Sell |
83,100
-88,000
| -51% | -$6.75M | ﹤0.01% | 2726 |
|
|
2019
Q1 | $16M | Buy |
171,100
+96,700
| +130% | +$8.09M | 0.01% | 2055 |
|
|
2018
Q4 | $5.42M | Buy |
74,400
+60,500
| +435% | +$4.65M | ﹤0.01% | 2809 |
|
|
2018
Q3 | $1.22M | Hold |
13,900
| – | – | ﹤0.01% | 3927 |
|
|
2018
Q2 | $1.37M | Buy |
+13,900
| New | +$1.38M | ﹤0.01% | 3872 |
|
|
2017
Q4 | – | Sell |
-76,600
| Closed | -$9M | – | 6311 |
|
|
2017
Q3 | $9M | Buy |
+76,600
| New | +$6.54M | ﹤0.01% | 2642 |
|
|
2016
Q4 | – | Sell |
-178,400
| Closed | -$12.1M | – | 6872 |
|
|
2016
Q3 | $12.1M | Sell |
178,400
-149,200
| -46% | -$10.5M | ﹤0.01% | 2298 |
|
|
2016
Q2 | $18.2M | Buy |
327,600
+600
| +0.2% | +$37.8K | 0.01% | 1862 |
|
|
2016
Q1 | $20.5M | Buy |
327,000
+287,000
| +718% | +$19.1M | 0.01% | 1698 |
|
|
2015
Q4 | $3.77M | Sell |
40,000
-81,500
| -67% | -$7.56M | ﹤0.01% | 3098 |
|
|
2015
Q3 | $9.76M | Sell |
121,500
-10,000
| -8% | -$1.11M | ﹤0.01% | 2270 |
|
|
2015
Q2 | $15.8M | Buy |
131,500
+17,700
| +16% | +$2.12M | 0.01% | 1979 |
|
|
2015
Q1 | $11.9M | Sell |
113,800
-17,900
| -14% | -$1.81M | ﹤0.01% | 2151 |
|
|
2014
Q4 | $12.8M | Sell |
131,700
-263,800
| -67% | -$24.4M | 0.01% | 2158 |
|
|
2014
Q3 | $30.9M | Buy |
395,500
+37,500
| +10% | +$2.42M | 0.01% | 1454 |
|
|
2014
Q2 | $22.6M | Buy |
+358,000
| New | +$21.3M | 0.01% | 1691 |
|
|
2013
Q4 | – | Sell |
-119,400
| Closed | -$7.64M | – | 6638 |
|
|
2013
Q3 | $7.64M | Buy |
119,400
+97,900
| +455% | +$4.88M | ﹤0.01% | 2519 |
|
|
2013
Q2 | $667K | Buy |
+21,500
| New | +$572K | ﹤0.01% | 4709 |
|
Other funds holding ALNY
VPM
VCM
